Literature DB >> 15581198

The impact of altitude on mortality from tuberculosis and pneumonia.

R Pérez-Padilla1, F Franco-Marina.   

Abstract

OBJECTIVE: To examine the association between altitude and mortality from tuberculosis (TB) and pneumonia-influenza in Mexico.
DESIGN: We analysed specific causes of death in Mexico according to death certificates for the period 1993-1997, totalling over 2,700,000 deaths and including nearly 23,000 attributed to TB and 115,000 to pneumonia and influenza. Thirty population subgroups were formed based on altitude of residence (six categories) and level of poverty (five categories). The effect of altitude on mortality was estimated through Poisson regression models, with adjustment for age, gender and socioeconomic status.
RESULTS: Adjusted death rates for TB decreased with altitude and increased for pneumonia-influenza. Compared to people living below 500 m above sea level, those living between 2000 and 2499 m had a 58% mortality rate for TB and a three-fold increase in mortality due to pneumonia-influenza, despite adjustment for poverty, age and gender.
CONCLUSION: The mortality rate for TB based on death certificates decreases with altitude of residence, whereas the opposite is observed for pneumonia and influenza.

Entities:  

Mesh:

Year:  2004        PMID: 15581198

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  12 in total

Review 1.  Effects of living at higher altitudes on mortality: a narrative review.

Authors:  Martin Burtscher
Journal:  Aging Dis       Date:  2013-12-05       Impact factor: 6.745

2.  Childhood anemia at high altitude: risk factors for poor outcomes in severe pneumonia.

Authors:  Peter P Moschovis; Salem Banajeh; William B MacLeod; Samir Saha; Douglas Hayden; David C Christiani; Greta Mino; Mathuram Santosham; Donald M Thea; Shamim Qazi; Patricia L Hibberd
Journal:  Pediatrics       Date:  2013-10-07       Impact factor: 7.124

3.  Effects of ascent to high altitude on human antimycobacterial immunity.

Authors:  Sarah Eisen; Louise Pealing; Robert W Aldridge; Mark J Siedner; Alejandro Necochea; Inna Leybell; Teresa Valencia; Beatriz Herrera; Siouxsie Wiles; Jon S Friedland; Robert H Gilman; Carlton A Evans
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

4.  Altitude and COPD prevalence: analysis of the PREPOCOL-PLATINO-BOLD-EPI-SCAN study.

Authors:  Andreas Horner; Joan B Soriano; Milo A Puhan; Michael Studnicka; Bernhard Kaiser; Lowie E G W Vanfleteren; Louisa Gnatiuc; Peter Burney; Marc Miravitlles; Francisco García-Rio; Julio Ancochea; Ana M Menezes; Rogelio Perez-Padilla; Maria Montes de Oca; Carlos A Torres-Duque; Andres Caballero; Mauricio González-García; Sonia Buist; Maria Flamm; Bernd Lamprecht
Journal:  Respir Res       Date:  2017-08-23

Review 5.  Altitude and COVID-19: Friend or foe? A narrative review.

Authors:  Grégoire P Millet; Tadej Debevec; Franck Brocherie; Martin Burtscher; Johannes Burtscher
Journal:  Physiol Rep       Date:  2021-01

6.  Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021.

Authors: 
Journal:  Lancet       Date:  2022-02-01       Impact factor: 202.731

7.  Therapeutic Use of Exercising in Hypoxia: Promises and Limitations.

Authors:  Gregoire P Millet; Tadej Debevec; Franck Brocherie; Davide Malatesta; Olivier Girard
Journal:  Front Physiol       Date:  2016-06-10       Impact factor: 4.566

8.  Positive association between moderate altitude and chronic lower respiratory disease mortality in United States counties.

Authors:  Jeongeun Hwang; Miso Jang; Namkug Kim; Seunghyun Choi; Yeon-Mok Oh; Joon Beom Seo
Journal:  PLoS One       Date:  2018-07-11       Impact factor: 3.240

9.  Trends of Human Plague, Madagascar, 1998-2016.

Authors:  Voahangy Andrianaivoarimanana; Patrice Piola; David M Wagner; Fanjasoa Rakotomanana; Viviane Maheriniaina; Samuel Andrianalimanana; Suzanne Chanteau; Lila Rahalison; Maherisoa Ratsitorahina; Minoarisoa Rajerison
Journal:  Emerg Infect Dis       Date:  2019-02       Impact factor: 6.883

10.  Modeling COVID-19 scenarios for the United States.

Authors: 
Journal:  Nat Med       Date:  2020-10-23       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.